Larvol Delta - Aspen-Receives-Adoption-of-Sasineprocel-as-the-Official-Nonproprietary-Naming-of-ANPD001-its-Investigational-Autologous-Cell-Therapy-for-the-Treatment-of-Parkinsons-Disease

sasineprocel (ANPD001) - Aspen Neurosci

https://www.prnewswire.com/news-releases/aspen-receives-adoption-of-sasineprocel-as-the-official-nonproprietary-naming-of-anpd001-its-investigational-autologous-cell-therapy-for-the-treatment-of-parkinsons-disease-302711623.html

Mar 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next